What modern eye measurements can reveal before refractive surgery?

A refractive-surgery consultation starts with a familiar number: the prescription. It tells the clinician how much myopia, hyperopia, or astigmatism needs correction. What it does not show is whether the cornea has a regular shape, how its thickness is distributed, whether higher-order optical aberrations are present, or whether the ocular surface is stable enough for surgery.

Those distinctions have made preoperative refractive assessment increasingly data-driven.

Modern screening can combine refraction with corneal imaging, pachymetry, wavefront aberrometry, tear-film assessment, and a comprehensive eye examination. Current American Academy of Ophthalmology guidance treats the preoperative evaluation as a clinical decision process rather than a prescription-to-procedure pipeline [1].

Steven J. Dell, MD, from Dell Laser Consultants, emphasizes individualized refractive evaluation. The practice’s published approach includes detailed candidacy assessment, optical measurements, and evaluation of ocular-surface health before vision-correction options are considered [8].

The broader principle applies beyond any one center: the value of a measurement is not that it produces more data, but that it can change the decision.

A prescription cannot describe everything about the eye

Consider two patients with the same -4.00 diopter prescription.

On paper, their refractive error may look almost identical. One could have a regular, relatively symmetric cornea with reassuring thickness characteristics and a stable ocular surface. The other could have subtle corneal asymmetry, suspicious posterior elevation, significant tear-film abnormalities, or optical aberrations that are not described by sphere and cylinder. The prescription alone does not distinguish those eyes.

Current refractive-surgery evaluation therefore extends beyond standard visual acuity and manifest refraction. The AAO’s Preferred Practice Pattern places preoperative assessment within a comprehensive medical eye evaluation, with the operating ophthalmologist responsible for determining whether surgery is appropriate [1].

For corneal laser procedures, one of the central questions is biomechanical: can the cornea tolerate the planned structural change? Postoperative ectasia, a progressive weakening and distortion of the cornea, is uncommon, but it is a serious complication.

Postoperative ectasia has been reported after PRK, LASIK, and SMILE [3]. For LASIK in particular, preoperative risk assessment considers factors such as abnormal topography, corneal thickness, patient age, residual stromal bed, and the percentage of tissue altered [4].

Older screening approaches relied heavily on anterior corneal shape and central corneal thickness. Those measurements still matter. The challenge is that risk is not captured by one thickness number or one curvature value.

Modern imaging adds information that a single central-thickness measurement cannot provide. Thickness distribution, elevation patterns, and relationships between different regions of the cornea can help reveal abnormalities that deserve closer evaluation before surgery [2,4].

Mapping the cornea in two and three dimensions

“Corneal mapping” can refer to several technologies, and the distinction between topography and tomography is clinically important.

Corneal topography primarily describes the curvature and shape of the corneal surface. Placido-based systems analyze reflected patterns from the anterior surface to identify features such as regular astigmatism, asymmetry, or patterns that may raise concern for keratoconus or other corneal irregularity.

Corneal tomography adds depth. Technologies such as rotating Scheimpflug imaging and swept-source anterior-segment OCT can generate three-dimensional information about the cornea, including anterior and posterior elevation and the spatial distribution of corneal thickness.

A 2026 review of topography and tomography in refractive surgery describes how newer imaging methods are improving the detection of subclinical keratoconus, biomechanical risk assessment, and personalized surgical planning [2]. The field is also moving toward combinations of 3D imaging, epithelial thickness mapping, biomechanical measurements, and algorithmic analysis rather than dependence on a single map.

Posterior-surface data can reveal information that anterior curvature alone may not show. Some early ectatic changes may therefore warrant closer investigation even when the front-surface pattern appears less conspicuous.

This does not make tomography an automatic pass-or-fail test. Modern imaging generates numerous indices, and thresholds differ by device, population, and clinical context. Even sophisticated screening cannot reduce ectasia susceptibility to one number [2,4].

Clinicians therefore look for agreement across the measurements and pay attention when the findings do not agree.

If refraction, anterior topography, posterior elevation, thickness distribution, biomechanics, ocular history, and planned tissue removal all point in the same direction, the clinician has a more coherent picture. When those datasets disagree, the disagreement itself may be clinically useful.

It may prompt repeat measurements, additional testing, a different procedure, or a decision not to operate.

Wavefront testing looks beyond conventional refractive error

Refraction measures lower-order optical errors well. Sphere describes nearsightedness or farsightedness, while cylinder and axis describe regular astigmatism.

Human vision is optically more complicated than those values suggest.

When light travels through the eye, imperfections in the optical system can cause the resulting wavefront to deviate from an ideal shape. Wavefront aberrometry measures those deviations. In addition to familiar lower-order refractive errors, it can quantify higher-order aberrations such as coma, trefoil, and spherical aberration [5].

These measurements help describe optical quality in ways a glasses prescription cannot.

Wavefront data have several roles in refractive care. They can help identify irregular optics, characterize higher-order aberrations, and, with compatible laser systems, contribute to wavefront-guided treatment planning [5].

But collecting a wavefront map is not the same as proving that every measured aberration should be treated.

Measurement quality matters. So do pupil conditions, ocular-surface stability, corneal shape, and the source of the aberration. Some aberrations may arise primarily from the cornea, while others involve the eye’s internal optics. A treatment strategy therefore has to be interpreted in the context of the rest of the examination.

Clinical evidence also argues against treating “wavefront-guided” as a synonym for universally superior. A meta-analysis comparing wavefront-guided LASIK with SMILE for myopia found differences in some higher-order aberration outcomes, but the relative advantages varied by optical parameter rather than pointing to one procedure as categorically better in every respect [6].

More sophisticated measurement can improve characterization without eliminating clinical tradeoffs.

The ocular surface adds another layer. Preoperative tear-film and surface findings matter because refractive surgery can affect dry-eye symptoms, and baseline abnormalities may help identify patients at greater risk of postoperative problems. In a prospective study of PRK and LASIK patients, lower preoperative tear production and greater ocular-surface staining were associated with chronic dry-eye development in specific procedure groups [7].

Preoperative assessment may include tear-production measures, tear-film stability, and ocular-surface staining, with abnormal findings addressed before elective surgery is considered [1,7].

Turning multiple measurements into one treatment decision

The technological challenge in modern refractive surgery is no longer simply acquiring measurements. It is deciding what to do when several measurements describe different aspects of the same eye.

A typical evaluation may need to answer several separate questions:

• Is the refractive error stable and suitable for surgical correction?
• Is the corneal shape regular?
• Does tomography raise concern for ectatic disease or susceptibility?
• Is there enough tissue for the proposed corneal procedure?
• Are higher-order aberrations clinically relevant to the treatment plan?
• Is the ocular surface healthy and stable?
• Are there other eye conditions that change the risk-benefit calculation?
• Which procedure best fits the anatomy rather than simply the prescription?

The appropriate pathway may be LASIK, PRK, a small-incision lenticule procedure, or in selected eyes a phakic intraocular lens or another non-corneal approach [1].

An ocular-surface problem may need treatment before measurements are repeated. Suspicious corneal findings may lead to further evaluation or rule out elective corneal refractive surgery altogether.

In other words, improved technology can make exclusion more informed as well as selection.

The same decision framework applies at the Austin-based practice discussed earlier. Its refractive pathways include LASIK and PRK, SMILE PRO, EVO ICL, and lens-based vision correction, while its dry-eye program uses multiple diagnostic modalities [8]. When several refractive approaches are available, the evaluation can focus on which option, if any, best matches the patient’s anatomy and clinical findings.

That is the real shift created by modern diagnostic technology. A prescription still matters, but it is only the first layer of the dataset. Topography describes surface shape. Tomography adds three-dimensional structural information. Wavefront aberrometry characterizes optical imperfections. Ocular-surface testing helps establish whether the front of the eye is healthy and stable. Clinical history and examination determine how those findings should be weighted.

The result is a preoperative assessment built from several complementary datasets rather than any single screening number.

References

[1] Jacobs, D. S., Lee, J. K., Shen, T. T., Afshari, N. A., Bishop, R. J., Keenan, J. D., & Vitale, S. (2023). Refractive Surgery Preferred Practice Pattern®. Ophthalmology, 130(3), P61–P135. doi: 10.1016/j.ophtha.2022.10.032.

[2] Fernandes, V. M., McGlone, C., Fernandez, K. B., & Rocha, K. M. (2026). Update on topography and tomography for refractive surgery. Current Opinion in Ophthalmology, 37(4), 267–274. doi: 10.1097/ICU.0000000000001226.

[3] Moshirfar, M., Tukan, A. N., Bundogji, N., Liu, H. Y., McCabe, S. E., Ronquillo, Y. C., & Hoopes, P. C. (2021). Ectasia after corneal refractive surgery: A systematic review. Ophthalmology and Therapy, 10(4), 753–776. doi: 10.1007/s40123-021-00383-w.

[4] Santhiago, M. R., Giacomin, N. T., Smadja, D., & Bechara, S. J. (2016). Ectasia risk factors in refractive surgery. Clinical Ophthalmology, 10, 713–720. doi: 10.2147/OPTH.S51313.

[5] Maeda, N. (2009). Clinical applications of wavefront aberrometry—A review. Clinical & Experimental Ophthalmology, 37(1), 118–129. doi: 10.1111/j.1442-9071.2009.02005.x.

[6] Tian, H., Gao, W., Xu, C., & Wang, Y. (2023). Clinical outcomes and higher-order aberrations of wavefront-guided LASIK versus SMILE for correction of myopia: A systematic review and meta-analysis. Acta Ophthalmologica, 101, 606–618. https://doi.org/10.1111/aos.15638

[7] Bower, K. S., Sia, R. K., Ryan, D. S., Mines, M. J., & Dartt, D. A. (2015). Chronic dry eye in PRK and LASIK: Manifestations, incidence and predictive factors. Journal of Cataract & Refractive Surgery, 41(12), 2624–2634. doi: 10.1016/j.jcrs.2015.06.037.

[8] DellVision.com. (n.d.). Practice facts. https://www.dellvision.com/facts/

This article is for educational purposes and does not replace individualized evaluation or medical advice from a qualified ophthalmologist.